CI

At a glance

ClinicalIndex Comparison Record
Phase 4Completed· 154 enrolled
Drug / intervention
Hydromorphone +1 moredrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT03300674
NCT03300674Phase 4Completed
CompareCT.gov

Intravenous Lidocaine Versus Hydromorphone for Acute Abdominal Pain. A Randomized Trial

Montefiore Medical Center·interventional·Posted Oct 3, 2017·Updated Aug 10, 2020

In Brief

A Phase 4 clinical trial evaluating Hydromorphone and Lidocaine for Abdominal Pain. Completed, enrolled 154 participants across 1 site.

Detailed Summary

This is a randomized, double-blind, emergency department based, comparative effectiveness study of two medication for acute abdominal pain: intravenous lidocaine and intravenous hydromorphone. Patients will be enrolled during an emergency department visit and followed throughout their emergency department course and then by telephone 7 days later.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsAbdominal Pain
CountriesUnited States
Collaborators--

Timeline

Phase 4CompletedFinished
201820192020202120222023202420252026
First PostedOct 3, 2017
Enrollment StartJan 10, 2018
Primary CompletionAug 16, 2018
Study CompletionAug 28, 2018
TodayJul 2, 2026
Enrollment to primary: 7 monthsPosted 8.7 years ago

Interventions

Hydromorphonedrug

Hydromorphone intravenous infusion

Lidocainedrug

Lidocaine intravenous infusion